Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged […]

VisitorsCoverage Partners with Atlys to Deliver Embedded Travel Insurance Technology, Enhancing Global Travel Experience

VisitorsCoverage Inc., an InsurTech100 company and pioneer in digital travel insurance, today announced a strategic partnership with Atlys, a visa processing platform. Through this collaboration, Atlys will integrate VisitorsCoverage's award-winning Treppy™ embedded insurance technology directly into its checkout journey, enabling travelers to seamlessly add comprehensive travel insurance protection while completing their visa applications. https://mma.prnewswire.com/media/2686792/VisitorsCoverage_Logo.jpg Revolutionizing

Pomerantz LLP Pursues Class Action Against Cepton, Inc. – CPTN

NEW YORK, NY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Braskem S.A. (BAK) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Braskem S.A. ("Braskem" or "the Company") (NYSE:BAK). Investors who purchased Braskem securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BAK. Investigation

Anew Climate and Seaspan Energy Complete First Bio-LNG Loading for Maritime Sector, Advancing Maritime Decarbonization

Ship-to-ship fueling operation in Long Beach demonstrates scalable, low-carbon marine fuel solution aligned with global climate goals NORTH VANCOUVER, BC AND HOUSTON, TX, NY / ACCESS Newswire / October 21, 2025 / In another landmark step toward maritime decarbonization, Anew Climate (Anew) and Seaspan Energy (Seaspan) have successfully completed their first ship-to-ship loading operation of

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to

Cornerstone Bancorp, Inc. Quarterly Report – September 30, 2025

CORNERSTONEBANCORP, INC. THIRD QUARTER 2025 HIGHLIGHTS (At or for period ended 9/30/2025) Income Statement Highlights — Consolidated net income was $2.9 million in 3Q25, or $2.99 per diluted share, compared to $2.6 million in 3Q24, or $2.69 per diluted share. — The net interest margin (NIM) was 3.75% for 3Q25, compared to 3.33% for 3Q24.

BURL CONCEPTS CLOSES CURRENT OVERSUBSCRIBED $4.5 MILLION INVESTMENT

Funding to support launch of non-invasive SONAS® ultrasound system in the Patent Foramen Ovale (PFO) market BURL Concepts, a private MedTech company focused on the development of a state-of-the-art, rapid, automated and affordable test for evaluating cerebral blood flow and detecting emboli, announced today the closing of its most recent funding. The recent funding now

Two Years Strong: Minneapolis’ First Public Nasal Naloxone Station Hits Major Milestone

SixSpeed's brand action expands access to harm reduction tools across the Twin Cities and beyond Two years ago, SixSpeed, a Minneapolis-based full-service advertising agency, installed a small metal box outside the Episcopal Church of Minnesota on West Broadway containing 40 doses of free NARCAN® and fentanyl test strips. That box launched the Overdose Prevention Project

Scroll to Top